Abstract
Human Gene TherapyVol. 34, No. 9-10 CorrectionFree AccessCorrection to: Genome Editing of Pik3cd Impedes Abnormal Retinal Angiogenesis, by Wu et al. Hum Gene Ther 2023;34(1-2):30-41; doi: 10.1089/hum.2022.079is erratum ofGenome Editing of Pik3cd Impedes Abnormal Retinal AngiogenesisPublished Online:17 May 2023https://doi.org/10.1089/hum.2022.079.correxAboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail In the January 2023 issue of Human Gene Therapy (vol. 34, no. 1-2; 30–41), the article titled Genome Editing of Pik3cd Impedes Abnormal Retinal Angiogenesis, by Wu et al. requires correction.The author byline originally appeared with the 13th author's name incorrectly published as GuomingZhaoWenyi Wu,1,2,3 Gaoen Ma,4 Hui Qi,5 Lijun Dong,5 Fang Chen,6 Yun Wang,5 Xingxing Mao,5 Xiaoqing Guo,2,3 Jing Cui,7 Joanne Aiko Matsubara,7 Bart Vanhaesebroeck,8 Xiaohe Yan,5Guoming Zhao,5 Shaochong Zhang,5,* and Hetian Lei 5,*The correct spelling of the author's name isGuomingZhangThe online version of the article has been corrected to reflect this. The authors apologize for the error.FiguresReferencesRelatedDetailsRelated articlesGenome Editing of Pik3cd Impedes Abnormal Retinal Angiogenesis17 Jan 2023Human Gene Therapy Volume 34Issue 9-10May 2023 InformationCopyright 2023, by Mary Ann Liebert, Inc., publishersTo cite this article:Correction to: Genome Editing of Pik3cd Impedes Abnormal Retinal Angiogenesis, by Wu et al. Hum Gene Ther 2023;34(1-2):30-41; doi: 10.1089/hum.2022.079.Human Gene Therapy.May 2023.471-471.http://doi.org/10.1089/hum.2022.079.correxPublished in Volume: 34 Issue 9-10: May 17, 2023Online Ahead of Print:May 3, 2023PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
